tisotumab vedotin
tisotumab vedotin is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including TIVDAK. Available dosage form: injection, powder, for solution.
Drug Details
- Generic Name
- tisotumab vedotin
- Brand Names
- TIVDAK
- Application Number
- BLA761208
- Sponsor
- Bamboo US Bidco LCC
- NDC Codes
- 3
- Dosage Forms
- INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TISOTUMAB VEDOTIN
Indications and Usage
1 INDICATIONS AND USAGE TIVDAK ® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. TIVDAK is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. ( 1 )